Bupa Cromwell Hospital and Australian-owned radiotherapy and cancer treatment specialist GenesisCare have entered into a partnership to create an internationally recognised centre of excellence at the hospital in Knightsbridge.
The centre, which will be called GenesisCare Centre for Radiotherapy at Cromwell Hospital, will expand the hospital’s existing radiotherapy services and provide a comprehensive combination of treatment options for all tumour groups, with integrated clinical pathways to Bupa Cromwell Hospital. Alongside a Varian Edge and Gamma Knife Icon system for radiosurgery, the centre will host London’s first MRI-Guided Linac for use outside of research purposes.
Bupa Cromwell Hospital director Phil Luce said: ‘We want Bupa Cromwell Hospital to be a centre of excellence in oncology. This partnership with GenesisCare will ensure our patients have fast access to market-leading radiotherapy services which caters to their individual needs. Working with GenesisCare means we will continue to deliver the outstanding treatment our patients expect and deserve.’
According to the hospital, access to MRI-Guided Linac represents a ‘step change in radiotherapy’ that significantly improves outcomes through more precise targeting of tumours.
GenesisCare CEO Dan Collins said: ‘Delivering better outcomes and rapid access for patients is how we started and will always be our mission. The partnership with Bupa means we’re able to deliver on that goal in London – for the many local and international patients who will access our care. We will be bringing the world’s most innovative technologies and working with the very best doctors in oncology to provide the highest quality, evidence-based care. Our future together is exciting, and we are looking forward to keeping everyone updated on our progress.’
The partnership, which launches officially next month, builds on GenesisCare’s existing collaboration with Bupa in Australia, where it has co-developed a cardiology database, and its partnership with Sanitas in Spain.
GenesisCare will invest in team training and technology at Bupa Cromwell Hospital over the coming months to improve the treatment pathway using its ‘Service of the Future’ model, which has been developed by combining best practices from some of the leading oncology hospitals and technology companies. The company also plans to invest in redesigning the department to create a more patient-focused environment and will introduce new services, including an innovative partial breast radiotherapy programme, a hydrogel programme to reduce side-effects for prostate cancer patients, and an exercise medicine programme.